Le Lézard
Classified in: Health, Business
Subjects: ERN, CCA, ERP, DIV

Aflac Incorporated Announces Fourth Quarter Results, Reports Fourth Quarter Net Earnings of $782 Million, 2019 Adjusted EPS In Line With Upwardly Revised Guidance, Affirms 2020 Adjusted EPS Outlook, Increases First Quarter Cash Dividend 3.7%


COLUMBUS, Ga., Feb. 4, 2020 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its fourth quarter results.

Total revenues were $5.6 billion during the fourth quarter of 2019, compared with $5.1 billion in the fourth quarter of 2018. Net earnings were $782 million, or $1.06 per diluted share, compared with $525 million, or $0.69 per diluted share a year ago.

Net earnings in the fourth quarter of 2019 included pretax net realized investment gains of $34 million, or $0.05 per diluted share, compared with pretax net losses of $322 million, or $0.42 per diluted share a year ago. Included in those net gains were $9 million of losses related to impairments and loan loss reserve changes. Pretax net realized gains also included $36 million in gains from changes in the fair value of equity securities and $10 million of losses from certain derivatives and foreign currency activities, as well as a $17 million gain from sales and redemptions.

The average yen/dollar exchange rate* in the fourth quarter of 2019 was 108.79, or 3.8% stronger than the average rate of 112.87 in the fourth quarter of 2018. For the full year, the average exchange rate was 109.07, or 1.2% stronger than the rate of 110.39 a year ago.

Adjusted earnings* in the fourth quarter were $756 million, compared with $779 million in the fourth quarter of 2018, reflecting a decrease of 3.0%. Adjusted earnings per diluted share* increased 1.0% to $1.03 in the quarter and included $3 million of pretax variable investment income on alternative investments, in line with the company's expectations. The stronger yen/dollar exchange rate impacted adjusted earnings per diluted share by $0.02. Adjusted earnings per diluted share excluding the impact of foreign currency* decreased 1.0% to $1.01.

For the full year of 2019, total revenues were up 2.5% to $22.3 billion, compared with $21.8 billion for the full year of 2018. Net earnings were $3.3 billion, or $4.43 per diluted share, compared with $2.9 billion, or $3.77 per diluted share, for the full year of 2018. Adjusted earnings for the full year of 2019 were $3.3 billion, or $4.44 per diluted share, compared with $3.2 billion, or $4.16 per diluted share, in 2018. Adjusted earnings also included $32 million of pretax variable investment income on alternative investments, of which $21 million was above the company's expectations. The stronger yen/dollar exchange rate impacted adjusted earnings per diluted share by $0.02.

Total investments and cash at the end of December 2019 were $138.1 billion, compared with $126.2 billion at December 31, 2018. In the fourth quarter, Aflac Incorporated repurchased $470 million, or 8.9 million of its common shares. For the full year, Aflac repurchased $1.6 billion, or 32.0 million of its common shares. At the end of December, the company had 37.1 million remaining shares authorized for repurchase.

Shareholders' equity was $29.0 billion, or $39.84 per share, at December 31, 2019, compared with $23.5 billion, or $31.06 per share, at  December 31, 2018. Shareholders' equity at the end of the fourth quarter included a net unrealized gain on investment securities and derivatives of $8.5 billion, compared with a net unrealized gain of $4.2 billion at December 31, 2018. Shareholders' equity at the end of the fourth quarter also included an unrealized foreign currency translation loss of $1.6 billion, compared with an unrealized foreign currency translation loss of $1.8 billion at December 31, 2018. The annualized return on average shareholders' equity in the fourth quarter was 10.7% and 12.6% for the full year.

Shareholders' equity excluding AOCI* was $22.3 billion, or $30.74 per share at December 31, 2019, compared with $21.3 billion, or $28.22 per share, at December 31, 2018. The annualized adjusted return on equity excluding foreign currency impact* in the fourth quarter was 13.4% and 15.1% for the full year.

AFLAC JAPAN

In yen terms, Aflac Japan's net premium income was ¥345.8 billion for the quarter, or 1.6% lower than a year ago, mainly due to limited-pay products reaching paid-up status. Net investment income, net of amortized hedge costs*, decreased 1.4% to ¥67.1 billion. Total revenues in yen declined 1.6% to ¥413.9 billion. Pretax adjusted earnings in yen for the quarter declined 8.8% on a reported basis and 7.2% on a currency-neutral basis. The pretax adjusted profit margin for the Japan segment was 19.8%, compared with 21.4% a year ago. This reflects a favorable benefit ratio in 2018 and elevated expenses driven by reinvestment in the business in 2019.

For the full year, net premium income in yen was ¥1.4 trillion, or 1.1% lower than a year ago. Net investment income, net of amortized hedge costs, increased 2.2% to ¥271.3 billion. Total revenues in yen were down 0.6% to ¥1.7 trillion. Pretax adjusted earnings were ¥354.8 billion, or 0.2% higher than a year ago.

In dollar terms, net premium income increased 2.1% to $3.2 billion in the fourth quarter. Net investment income, net of amortized hedge costs, increased 2.7% to $618 million. Total revenues increased by 2.2% to $3.8 billion. Pretax adjusted earnings declined 5.1% to $757 million.

For the full year, net premium income in dollars was $12.8 billion, or 0.1% higher than a year ago. Net investment income, net of amortized hedge costs, increased 3.9% to $2.5 billion. Total revenues were up 0.7% to $15.3 billion. Pretax adjusted earnings were $3.3 billion, or 1.7% higher than a year ago.

For the quarter, new annualized premium sales (sales) for protection-type first sector and third sector products decreased 23.6% to ¥18.1 billion, and total sales decreased 23.4% to ¥18.5 billion, or $170 million.

For the full year, sales for protection-type first sector and third sector products decreased 16.8% to ¥78.2 billion, and total sales decreased 16.9% to ¥79.7 billion, or $731 million.

AFLAC U.S.

Aflac U.S. net premium income rose 1.1% to $1.4 billion in the fourth quarter. Net investment income decreased 1.6% to $180 million. Total revenues were up 1.6% to $1.6 billion. Pretax adjusted earnings were $275 million, 0.4% higher than a year ago, despite higher anticipated expenses in the quarter. The pretax adjusted profit margin for the U.S. segment was 16.8%, compared with 17.0% a year ago.

For the full year, net premium income rose 1.8% to $5.8 billion. Net investment income decreased slightly by 1.0% to $720 million. Total revenues were up 1.7% to $6.6 billion. Pretax adjusted earnings were $1.3 billion, 1.0% lower than a year ago.

Aflac U.S. sales decreased 0.7% in the quarter to $534 million. For the full year, total new sales decreased 1.3% to $1.6 billion.

CORPORATE AND OTHER

For the quarter, total revenue increased 14.0% to $106 million, reflecting net investment income of $50 million and lower corporate expenses. Net investment income, which increased $12 million, benefited from a $27 million pretax contribution from the company's enterprise corporate hedging program. Pretax adjusted earnings were a loss of $9 million, compared with a loss of $26 million a year ago.

For the full year, total revenue increased 15.9% to $393 million, reflecting net investment income of $177 million. Net investment income, which increased $64 million, benefited from a $89 million pretax contribution from the company's enterprise corporate hedging program. Pretax adjusted earnings were a loss of $72 million, compared with a loss of $139 million a year ago.

DIVIDEND

The board of directors declared the first quarter dividend of $0.28 per share, payable on March 2, 2020 to shareholders of record at the close of business on February 19, 2020.

OUTLOOK

Commenting on the company's results, Chairman and Chief Executive Officer Daniel P. Amos stated: "We are pleased with the company's overall performance for the year. Total pretax adjusted earnings increased 2.5%, which is particularly impressive considering our extensive investments to drive future earned premium growth, which will remain a critical strategic focus for 2020. I am pleased with the Board's decision to increase the dividend, coming off our 37th consecutive year of dividend increases and a recognition of the stability of our earnings and capital generation. It also demonstrates our commitment to rewarding our shareholders.

"As expected, Aflac Japan saw a decline in total earned premium in 2019 mainly due to limited-pay policies reaching paid-up status, which has minimal effect on profitability. Additionally, as we anticipated, full-year third sector and first sector protection sales were down in the mid-teens, primarily reflecting reduced sales of our cancer insurance through Japan Post and following a strong 2018 with the launch of our revised cancer insurance product. Earned premium growth for third and first sector protection products was 1.3%, which was in line with our expectation. As communicated on our 2020 outlook call, we expect a decline in the range of 0.7% in third sector and first sector protection earned premium for the year.

"With respect to our U.S. operations, our financial results for the year were consistent with our expectations and reflected elevated expenses as a result of ongoing investments in our platform, distribution and customer experience. While sales were down slightly for the year, earned premium grew 1.8%. In line with what we communicated on the 2020 outlook call, we expect Aflac U.S. to generate earned premium growth in the range of 1% and maintain stable persistency. We will continue to invest in product development and efforts to facilitate producer growth and productivity, including the measured roll-out of Aflac Dental and Vision that was initiated in January.

"Turning to investments, net investment income closed out a strong year in the face of lower rates in the U.S. and Japan, while at the same time positioning the credit quality of the portfolio to perform well should there be economic weakness. Consistent with Aflac Global Investments' business strategy, we closed on the acquisition of a non-controlling minority interest in Varagon Capital Partners in January 2020, where we are also making a multi-year commitment to build a portfolio of middle market loans.  A natural extension of our external manager program, we expect this strategy to deliver incremental value in future years.

"We remain committed to maintaining strong capital ratios on behalf of our policyholders and maintaining a strong risk-based capital ratio in the U.S. and solvency margin ratio in Japan. We will also continue to reinvest in our business, recognizing that prudent investment in our platform is also critical to our growth strategy and driving efficiencies that ultimately will impact the bottom line. We balance reinvestment with a focus on increasing the dividend and repurchasing shares. We expect share repurchase will be in the range of $1.3 to $1.7 billion in 2020, with the range allowing us to be more tactical in our deployment strategy. As always, this assumes stable capital conditions and the absence of compelling alternatives.

"As we look to 2020, our objective is to produce stable adjusted earnings per diluted share of $4.32 to $4.52, assuming the 2019 weighted-average exchange rate of 109.07 yen to the dollar. As always, we are working very hard to achieve our earnings-per-share objective while also ensuring we deliver on our promise to policyholders."

*See Non-U.S. GAAP Financial Measures section for an explanation of foreign exchange and its impact on the financial statements and definitions of the non-U.S. GAAP financial measures used in this earnings release, as well as a reconciliation of such non-U.S. GAAP financial measures to the most comparable U.S. GAAP financial measures.

ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL) is a Fortune 500 company, helping provide protection to more than 50 million people through its subsidiaries in Japan and the U.S., where it is a leading supplemental insurer by paying cash fast when policyholders get sick or injured. For more than six decades, insurance policies of Aflac Incorporated's subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. Aflac Life Insurance Japan is the leading provider of medical and cancer insurance in Japan, where it insures 1 in 4 households. Through its trailblazing One Day PaySM initiative in the United States, for eligible claims, Aflac can process, approve and electronically send funds to claimants for quick access to cash in just one business day. Fortune magazine recognized Aflac as one of the 100 Best Companies to Work for in America for 20 consecutive years. For 13 consecutive years, Aflac has been recognized by Ethisphere as one of the World's Most Ethical Companies. In 2020, Fortune included Aflac Incorporated on its list of World's Most Admired Companies for the 19th time, and Bloomberg added Aflac Incorporated to its Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation and transparency. To find out more about One Day PaySM and learn how to get help with expenses health insurance doesn't cover, get to know us at aflac.com.

Aflac herein means American Family Life Assurance Company of Columbus and American Family Life Assurance Company of New York.

A copy of Aflac's Financial Analysts Briefing (FAB) supplement for the quarter can be found on the "Investors" page at aflac.com.

Aflac Incorporated will webcast its quarterly conference call via the "Investors" page of aflac.com at 9:00 a.m. (ET) on Wednesday, February 5, 2020.

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT

(UNAUDITED ? IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)








THREE MONTHS ENDED DECEMBER 31,


2019


2018


% Change

Total revenues


$

5,603



$

5,126



9.3

%

Benefits and claims, net


2,985



2,925



2.1


Total acquisition and operating expenses


1,560



1,479



5.5


Earnings before income taxes


1,058



722



46.5


Income taxes


276



197




Net earnings


$

782



$

525



49.0

%

Net earnings per share ? basic


$

1.07



$

0.69



55.1

%

Net earnings per share ? diluted


1.06



0.69



53.6


Shares used to compute earnings per share (000):







Basic


733,358



760,037



(3.5)

%

Diluted


737,463



765,103



(3.6)


Dividends paid per share


$

0.27



$

0.26



3.8

%

 

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT

(UNAUDITED ? IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)








TWELVE MONTHS ENDED DECEMBER 31,


2019


2018


% Change

Total revenues


$

22,307



$

21,758



2.5

%

Benefits and claims, net


11,942



12,000



(0.5)


Total acquisition and operating expenses


5,920



5,775



2.5


Earnings before income taxes


4,445



3,983



11.6


Income taxes


1,141



1,063




Net earnings


$

3,304



$

2,920



13.2

%

Net earnings per share ? basic


$

4.45



$

3.79



17.4

%

Net earnings per share ? diluted


4.43



3.77



17.5


Shares used to compute earnings per share (000):







Basic


742,414



769,588



(3.5)

%

Diluted


746,430



774,650



(3.6)


Dividends paid per share


$

1.08



$

1.04



3.8

%

 

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED BALANCE SHEET

(UNAUDITED ? IN MILLIONS, EXCEPT FOR SHARE AMOUNTS)








DECEMBER 31,


2019


2018


% Change

Assets:







Total investments and cash


$

138,091



$

126,243



9.4

%

Deferred policy acquisition costs


10,128



9,875



2.6


Other assets


4,549



4,288



6.1


Total assets


$

152,768



$

140,406



8.8

%

Liabilities and shareholders' equity:







Policy liabilities


$

106,554



$

103,188



3.3

%

Notes payable and lease obligations


6,569



5,778



13.7


Other liabilities


10,686



7,978



33.9


Shareholders' equity


28,959



23,462



23.4


Total liabilities and shareholders' equity


$

152,768



$

140,406



8.8

%

Shares outstanding at end of period (000)


726,793



755,286



(3.8)

%

NON-U.S. GAAP FINANCIAL MEASURES

This earnings release includes references to Aflac's non-U.S. GAAP financial measures, adjusted earnings, adjusted earnings per diluted share, adjusted return on equity, amortized hedge costs/income, and adjusted book value. These measures are not calculated in accordance with U.S. GAAP. The measures exclude items that the company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations. Management uses adjusted earnings, adjusted earnings per diluted share, and adjusted return on equity to evaluate the financial performance of Aflac's insurance operations on a consolidated basis and believes that a presentation of these measures is vitally important to an understanding of the underlying profitability drivers and trends of Aflac's insurance business. The company believes that amortized hedge costs/income, which are a component of adjusted earnings, measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. The company considers adjusted book value important as it excludes accumulated other comprehensive income (AOCI), which fluctuates due to market movements that are outside management's control. Definitions of the company's non-U.S. GAAP financial measures and reconciliations to the most comparable U.S. GAAP measures are provided below and in the following schedules.

Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the yen weakens, translating yen into dollars results in fewer dollars being reported. When the yen strengthens, translating yen into dollars results in more dollars being reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the company's business is conducted in yen and never converted into dollars but translated into dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Because foreign exchange rates are outside of management's control, Aflac believes it is important to understand the impact of translating Japanese yen into U.S. dollars. Adjusted earnings, adjusted earnings per diluted share, and adjusted return on equity, all excluding current period foreign currency impact, are computed using the average yen/dollar exchange rate for the comparable prior year period, which eliminates fluctuations driven solely by yen-to-dollar currency rate changes. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).

The company defines the non-U.S. GAAP financial measures included in this earnings release as follows:

RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS1

(UNAUDITED ? IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)








THREE MONTHS ENDED DECEMBER 31,


2019


2018


% Change








Net earnings


$

782



$

525



49.0

%








Items impacting net earnings:







Realized investment (gains) losses


(34)



322




Other and non-recurring (income) loss


?



2




Income tax (benefit) expense on items excluded

from adjusted earnings


12



(77)




   Tax reform adjustment 4


(4)



7











Adjusted earnings


756



779



(3.0)

%

Current period foreign currency impact 2


(13)



N/A




Adjusted earnings excluding current period foreign 

     currency impact 3


$

744



$

779



(4.5)

%








Net earnings per diluted share


$

1.06



$

0.69



53.6

%








Items impacting net earnings:







Realized investment (gains) losses


(0.05)



0.42




Other and non-recurring (income) loss


?



?




Income tax (benefit) expense on items excluded

from adjusted earnings


0.02



(0.10)




   Tax reform adjustment 4


(0.01)



0.01











Adjusted earnings per diluted share


1.03



1.02



1.0

%

Current period foreign currency impact 2


(0.02)



N/A




Adjusted earnings per diluted share excluding 

     current period foreign currency impact 3


$

1.01



$

1.02



(1.0)

%



1  

Amounts may not foot due to rounding.

2   

Prior period foreign currency impact reflected as "N/A" to isolate change for current period only.

3   

Amounts excluding current period foreign currency impact are computed using the average yen/dollar exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by yen-to-dollar currency rate changes.

4   

The impact of Tax Reform was adjusted in 2018 for return-to-provision adjustments, various amended returns filed by the company, and final true-ups of deferred tax liabilities. Further impacts were recorded in 2019 as a result of additional guidance released by the IRS.

 

RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS1

(UNAUDITED ? IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)








TWELVE MONTHS ENDED DECEMBER 31,


2019


2018


% Change








Net earnings


$

3,304



$

2,920



13.2

%








Items impacting net earnings:







Realized investment (gains) losses


15



297




Other and non-recurring (income) loss


1



75




Income tax (benefit) expense on items excluded

from adjusted earnings


(3)



(83)




   Tax reform adjustment 4


(4)



18











Adjusted earnings


3,314



3,226



2.7

%

Current period foreign currency impact 2


(15)



N/A




Adjusted earnings excluding current period foreign 

     currency impact 3


$

3,299



$

3,226



2.3

%








Net earnings per diluted share


$

4.43



$

3.77



17.5

%








Items impacting net earnings:







Realized investment (gains) losses


0.02



0.38




Other and non-recurring (income) loss


?



0.10




Income tax (benefit) expense on items excluded

from adjusted earnings


?



(0.11)




   Tax reform adjustment 4


(0.01)



0.02











Adjusted earnings per diluted share


4.44



4.16



6.7

%

Current period foreign currency impact 2


(0.02)



N/A




Adjusted earnings per diluted share excluding 

     current period foreign currency impact 3


$

4.42



$

4.16



6.3

%



1  

Amounts may not foot due to rounding.

2 

Prior period foreign currency impact reflected as "N/A" to isolate change for current period only.

3  

Amounts excluding current period foreign currency impact are computed using the average yen/dollar exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by yen-to-dollar currency rate changes.

4   

The impact of Tax Reform was adjusted in 2018 for return-to-provision adjustments, various amended returns filed by the company, and final true-ups of deferred tax liabilities. Further impacts were recorded in 2019 as a result of additional guidance released by the IRS.

 

RECONCILIATION OF U.S. GAAP BOOK VALUE TO ADJUSTED BOOK VALUE 1

(UNAUDITED - IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)








DECEMBER 31,


2019


2018


% Change

U.S. GAAP book value


$

28,959



$

23,462




Less:







Unrealized foreign currency translation gains (losses)


(1,623)



(1,847)




Unrealized gains (losses) on securities and derivatives


8,515



4,210




Pension liability adjustment


(277)



(212)




Total AOCI


6,615



2,151




Adjusted book value 2


$

22,344



$

21,311




Add:







Unrealized foreign currency translation gains (losses)


(1,623)



(1,847)




Adjusted book value including unrealized foreign currency
   translation gains (losses) 3


$

20,721



$

19,464











Number of outstanding shares at end of period (000)


726,793



755,286











U.S. GAAP book value per common share


$

39.84



$

31.06



28.3

%

Less:







Unrealized foreign currency translation gains (losses)
   per common share


(2.23)



(2.45)




Unrealized gains (losses) on securities and derivatives
   per common share


11.72



5.57




Pension liability adjustment per common share


(0.38)



(0.28)




Total AOCI per common share


9.10



2.85




Adjusted book value per common share 4


$

30.74



$

28.22



8.9

%

Add:







Unrealized foreign currency translation gains (losses)
   per common share


(2.23)



(2.45)




Adjusted book value including foreign currency translation
   gains (losses) per common share 3


$

28.51



$

25.77



10.6

%



1   

Amounts may not foot due to rounding.

2  

Adjusted book value is the U.S. GAAP book value (representing total shareholder's equity), excluding AOCI (as recorded on the U.S. GAAP balance sheet).

3   

Adjusted book value including unrealized foreign currency translation gains (losses) is adjusted book value plus unrealized foreign currency translation gains (losses).

4   

Adjusted book value per share is the adjusted book value at the period ended divided by the ending outstanding common shares for the period presented. The most comparable U.S. GAAP measure is total book value per share.

 

RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE 1

(EXCLUDING IMPACT OF FOREIGN CURRENCY)






THREE MONTHS ENDED DECEMBER 31,


2019


2018

Net earnings - U.S. GAAP ROE 2


10.7

%


9.0

%

Impact of excluding unrealized foreign currency translation gains (losses)


(0.7)



(0.9)


Impact of excluding unrealized gains (losses) on securities and derivatives


4.2



1.9


Impact of excluding pension liability adjustment


(0.1)



(0.1)


Impact of excluding AOCI


3.3



0.9


U.S. GAAP ROE - less AOCI


14.0



9.9


Differences between adjusted earnings and net earnings 3


(0.5)



4.8


Adjusted ROE - reported


13.6



14.6


Less: Impact of foreign currency 4


0.2



N/A


Adjusted ROE, excluding impact of foreign currency


13.4



14.6




1   

Amounts presented may not foot due to rounding.

2   

U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

3   

See separate reconciliation of net income to adjusted earnings.

4   

Impact of foreign currency is calculated by restating all yen components of the income statement to the weighted average yen rate for the comparable prior year period. The impact is the difference of the restated adjusted earnings compared to reported adjusted earnings. For comparative purposes, only current period income is restated using the weighted average prior period exchange rate, which eliminates the foreign currency impact for the current period. This allows for equal comparison of this financial measure.

 

RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE 1

(EXCLUDING IMPACT OF FOREIGN CURRENCY)






TWELVE MONTHS ENDED DECEMBER 31,


2019


2018

Net earnings - U.S. GAAP ROE 2


12.6

%


12.2

%

Impact of excluding unrealized foreign currency translation gains (losses)


(1.0)



(1.0)


Impact of excluding unrealized gains (losses) on securities and derivatives


3.6



3.0


Impact of excluding pension liability adjustment


(0.1)



(0.1)


Impact of excluding AOCI


2.5



1.8


U.S. GAAP ROE - less AOCI


15.1



13.9


Differences between adjusted earnings and net earnings 3


?



1.5


Adjusted ROE - reported


15.2



15.4


Less: Impact of foreign currency 4


0.1



N/A


Adjusted ROE, excluding impact of foreign currency


15.1



15.4




1   

Amounts presented may not foot due to rounding.

2   

U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

3   

See separate reconciliation of net income to adjusted earnings.

4   

Impact of foreign currency is calculated by restating all yen components of the income statement to the weighted average yen rate for the comparable prior year period. The impact is the difference of the restated adjusted earnings compared to reported adjusted earnings. For comparative purposes, only current period income is restated using the weighted average prior period exchange rate, which eliminates the foreign currency impact for the current period. This allows for equal comparison of this financial measure.

 

EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS1

(SELECTED PERCENTAGE CHANGES, UNAUDITED)


THREE MONTHS ENDED DECEMBER 31, 2019


Including

Currency

Changes


Excluding

Currency

Changes2

Net premium income 3


1.7

%


(0.9)

%

Net investment income 4


2.9



1.5


Total benefits and expenses


3.2



0.5


Adjusted earnings


(3.0)



(4.5)


Adjusted earnings per diluted share


1.0



(1.0)




Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

Amounts excluding currency changes were determined using the same yen/dollar exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes.

Net of reinsurance

Less amortized hedge costs/income on foreign investments

 

EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS1

(SELECTED PERCENTAGE CHANGES, UNAUDITED)


TWELVE MONTHS ENDED DECEMBER 31, 2019


Including

Currency

Changes


Excluding

Currency

Changes2

Net premium income 3


0.6

%


(0.3)

%

Net investment income 4


4.7



4.1


Total benefits and expenses


0.9



0.0


Adjusted earnings


2.7



2.3


Adjusted earnings per diluted share


6.7



6.3




Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

Amounts excluding currency changes were determined using the same yen/dollar exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes.

Net of reinsurance

Less amortized hedge costs/income on foreign investments

 




2020 ADJUSTED EARNINGS PER SHARE1 SCENARIOS2






















Weighted-Average
Yen/Dollar

Exchange Rate




Adjusted Earnings
Per

Diluted Share




Foreign

 Currency
Impact



100




$ 4.46

-

$ 4.66





$ 0.18




105




4.39

-

4.59





0.09




110




4.30

-

4.50





-




115




4.23

-

4.43





(0.07)




120




4.16

-

4.36





(0.14)





1   

A non-U.S. GAAP financial measure, adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted  average outstanding shares (basic or diluted) for the period presented. In reliance on the "unreasonable efforts" exception in Item 10(e)(1)(i)(B) of SEC Regulation S-K, a quantitative reconciliation to the most comparable U.S. GAAP measure is not provided for this financial measure. Forward-looking information with regard to the most comparable U.S. GAAP financial measure, earnings per share, is not available without unreasonable  effort. This is due to the unpredictable and uncontrollable nature of these reconciling items, which would require an unreasonable effort to forecast and we believe would result in such a broad range of projected values that would not be meaningful to investors. For this reason, we believe that the probable significance of such information is low.

2   

Table recasts all quarters to the average exchange rate.

FORWARD-LOOKING INFORMATION

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. The company desires to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as "expect," "anticipate," "believe," "goal," "objective," "may," "should," "estimate," "intends," "projects," "will," "assumes," "potential," "target," "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. Aflac undertakes no obligation to update such forward-looking statements.

The company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:

  • events related to the ongoing Japan Post investigation
  • difficult conditions in global capital markets and the economy
  • exposure to significant interest rate risk
  • concentration of business in Japan
  • foreign currency fluctuations in the yen/dollar exchange rate
  • limited availability of acceptable yen-denominated investments
  • U.S. tax audit risk related to conversion of the Japan branch to a subsidiary
  • deviations in actual experience from pricing and reserving assumptions
  • ability to continue to develop and implement improvements in information technology systems
  • competitive environment and ability to anticipate and respond to market trends
  • ability to protect the Aflac brand and the Company's reputation
  • ability to attract and retain qualified sales associates, brokers, employees, and distribution partners
  • interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems
  • failure to comply with restrictions on patient privacy and information security
  • extensive regulation and changes in law or regulation by governmental authorities
  • tax rates applicable to the Company may change
  • defaults and credit downgrades of investments
  • decline in creditworthiness of other financial institutions
  • significant valuation judgments in determination of amount of impairments taken on the Company's investments
  • subsidiaries' ability to pay dividends to the Parent Company
  • decreases in the Company's financial strength or debt ratings
  • inherent limitations to risk management policies and procedures
  • concentration of the Company's investments in any particular single-issuer or sector
  • differing judgments applied to investment valuations
  • ability to effectively manage key executive succession
  • catastrophic events including, but not necessarily limited to, epidemics, pandemics, tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events
  • changes in accounting standards
  • increased expenses and reduced profitability resulting from changes in assumptions for pension and other postretirement benefit plans
  • level and outcome of litigation
  • allegations or determinations of worker misclassification in the United States

 

Aflac Logo. (PRNewsFoto/Aflac)

Analyst and investor contact - David A. Young, 706.596.3264 or 800.235.2667 or [email protected]

Media contact - Catherine H. Blades, 706.596.3014; FAX: 706.320.2288 or [email protected]

SOURCE Aflac Incorporated


These press releases may also interest you

at 17:06
Spring is the perfect time to refresh your skin and revamp your daily skincare routine. As summer approaches, it's important to have a strong skin barrier and the products you need to protect it. As the founder of Nash Injections by Hannah, a...

at 17:05
Carisma Therapeutics Inc.  ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced its upcoming presentation at the American Society of Clinical...

at 17:00
LifeSpeak Inc. ("LifeSpeak" or the "Company") , the leading whole-person wellbeing solution for employers, health plans and other organizations, announced today that it will release its first quarter 2024 financial results before market open on...

at 16:59
The Honourable Mark Holland, Minister of Health, will host an event in Oshawa to highlight Budget 2024's investments in Canada's electric vehicle supply chain and the future of Canada's automotive industry. A media availability will follow the...

at 16:56
Hartford HealthCare is among the top 20% of hospitals nationwide recognized for outstanding patient safety ratings and the highest level of adherence to federal price transparency rules....

at 16:40
Pfizer Inc. today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company's common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The...



News published on and distributed by: